PROTON-TECHNOLOGIES
Clear Hydrogen UK Ltd. (CHUK) is pleased to announce an expansion of its agreement with Proton Technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220424005124/en/
Proton has the lowest-cost method for producing Clear Hydrogen, which is the most environmentally friendly and lowest cost method to make hydrogen.
The plan is to produce Clear Hydrogen from the UK’s aging offshore oil assets while sequestering vast amounts of CO2 as solid carbonate within the same systems.
In 2021, CHUK’s founders invested $3.7 million CAD in Proton to obtain a 20 tonne per day production license for use in the UK and Ireland. The expansion announced today is 250x larger, giving an implied total license value as high as $925 million CAD for 5000 tonnes per day. Terms include 45% ownership of CHUK going to Proton, who will be providing increased technical support and governance oversight to CHUK’s team. Two of CHUK’s founders will also be joining the board of Proton.
Chairman of CHUK Hertford King had this to say: “We look forward to the jobs and economic security this will bring to the UK using Proton’s low cost, carbon negative technology to leverage the equipment, assets, offshore knowledge, and people who already support the UK’s offshore energy production. Our intention is for CHUK to be an important component of the UK’s drive to become low carbon energy independent, and our agreement with Proton is a big step in helping us achieve this goal.”
Chairman of Proton Technologies, Grant Strem said “Our mission is to proliferate this hugely-scalable clean energy technology worldwide as fast as we can afford to. We like partnering with decisive and capable groups like CHUK to fill offtake deals already in advanced discussions. Adapting Proton’s hardware solutions to an offshore setting is easily within the technical grasp of experts in the UK, and this partnership with CHUK is good news for the environment and the UK economy generally. The energy sector is roughly $10 trillion per year. We expect to produce hydrogen at a lower energy cost than natural gas; the implications of this are profound.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20220424005124/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting indgår samarbejdsaftale med DEX Ventures12.6.2025 05:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sit udbud af digital transformation med tilføjelsen af samarbejdspartneren DEX Ventures, der er et digitalt marketingbureau med speciale i vækststrategi og digital innovation. DEX Ventures tilbyder en omfattende portefølje af ydelser, der kombinerer strategi, performance marketing, design og digitale løsninger. Deres udbud omfatter vækstrådgivning for at støtte brandstrategier, effektivitet og kundeerhvervelsesprogrammer med brug af medier og analyseværktøjer, visuelle og UX-designtjenester samt udvikling af indhold og fællesskaber. Virksomheden leverer primært deres ydelser til multinationale selskaber og Fortune 500-virksomheder inden for forskellige brancher, herunder teknologi, olie og gas samt detailhandel. Alex Ooi, der er administrerende direktør for DEX Ventures, udtalte: "Vi er glade for at indgå et samarbejde med Andersen Consulting og drage fordel af organisationens globale platform og ekspertise for at kunne tilbyde endnu bedre støtte til kunder
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications11.6.2025 22:05:00 CEST | Press release
New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of administration—while preserving flexible dosing options BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of BRUKINSA® (zanubrutinib) for all five approved indications. BRUKINSA remains the leader in new chronic lymphocytic leukemia (CLL) patient starts across all lines of therapy in the U.S., and for the first time, has become the overall BTK inhibitor market share leader.1 BRUKINSA tablets have the same efficacy and safety as BRUKINSA capsules based on the results of two single-dose, open-label, randomized Phase 1 crossover studies of healthy adults designed to establish bioequivalence. BRUKINSA is the only BTK inhibitor to offer the flexibility of once or twice daily dosing, with the ability to tailor the schedule to patient needs.
Visa Signs Football Phenom Lamine Yamal as a Global Ambassador for FIFA World Cup 26™11.6.2025 18:00:00 CEST | Press release
Marking the one-year countdown, Visa kicks off exclusive fan access and experiences tied to one of the sport’s most exciting young stars and more to come as the tournament approaches With exactly one year to go until the FIFA World Cup 26™ kicks off across Canada, Mexico and the United States, Visa (NYSE: V) — a global leader in digital payments and long-standing supporter of world football — today announced that Lamine Yamal, one of the game’s brightest rising stars, will serve as a global ambassador for the tournament. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611548983/en/ Football phenom Lamine Yamal waves alongside headline announcing Visa signed him as a Global Ambassador for the FIFA World Cup 2026™ To celebrate the milestone and build momentum toward the largest FIFA World Cup™ in history, Visa will unlock exclusive fan experiences for cardholders — including meet-and-greet opportunities with Lamine Yamal in
PubNub Evolves Its Platform with AI-Native Development, Real-Time Moderation, and Decision Intelligence11.6.2025 17:07:00 CEST | Press release
AI meets interactivity with built-in moderation, generative coding, and instant optimization for next-gen digital experiences. PubNub, the leader in real-time interactive apps, unveiled the next evolution of its platform. It introduces AI-native development, real-time decision intelligence, and in-network content moderation to help developers build and scale faster while simplifying access to PubNub's full power. The updates enable developers to build rich, real-time experiences like multiplayer games, collaborative tools, and healthcare apps with greater speed and control. “The world expects real-time, intelligent experiences,” said Todd Greene, CEO, PubNub. “Our evolved platform brings AI, analytics, and moderation into the developer workflow, enabling safer, smarter apps with lower latency and greater impact.” New Capabilities That Redefine Real-Time: Generative AI Coding with MCP Server PubNub’s new Model Context Protocol (MCP) Server connects large language models (LLMs) like thos
Grid Dynamics Releases Intralogistics Optimization Starter Kit for NVIDIA Omniverse11.6.2025 15:15:00 CEST | Press release
Key Takeaways: The Intralogistics Optimization Starter Kit enables retailers, manufacturers, and logistics companies to improve facility layouts and picking paths—boosting warehouse efficiency, reducing labor costs, and avoiding the risks and costs of trial-and-error changes. The solution combines large-scale, physics-accurate simulations built on NVIDIA Omniverse technologies with advanced optimization algorithms developed by Grid Dynamics, and aims to accelerate AI-driven transformation in supply chain and smart manufacturing operations. This release expands Grid Dynamics’ portfolio of supply chain intelligence accelerators, responding to strong client demand for scenario simulation and digital twins. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics), a leading provider of technology consulting, platform and product engineering, AI, and digital engagement services, today announced the launch of its Intralogistics Optimization Starter Kit for NVIDIA Omniverse. This advanced
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom